- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03372408
Parkdale Infant Nutrition Security Targeted Evaluation Project: Chart Review (PINSTEP-1)
Parkdale Infant Nutrition Security Targeted Evaluation Project (PINSTEP): Formative Research (Objective 1-Retrospective Chart Review)
In Toronto Ontario, the Parkdale Community Health Centre operates a community outreach program entitled Parkdale Parents' Primary Prevention Project (5P's). The 5P's provides weekly pre- and post-natal support and education programs for clients. This includes an infant feeding program for mothers with infants 0-6 months (Feeding Tiny Souls). The 5P's has a diverse client-base; the program is aimed at women who are in challenging life circumstances, therefore, clients may include low-income or single mothers and newcomers to Canada.
It is important to know who is accessing community programs and what the drivers of program utilization are in order to better support the women who are enrolled and to target those who are not. The aim of this project is twofold: 1) to investigate what socio-demographic and psychosocial characteristics predict level of participation in a prenatal community outreach program targeting vulnerable mothers and 2) based on utilization of a prenatal program, are there differences in the use of a postnatal program? This study will be conducted through a retrospective chart review. The study population will consist of women who enrolled in 5P's prenatally. The hypothesis is that more vulnerable women will not attend programming as frequently.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6R 3B2
- Parkdale Community Health Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Enrolled in Parkdale Parents' Primary Prevention Project (5P's) prenatally
- 5P's client signed the permission to release information on the 5P's intake form
Exclusion Criteria:
- Only attended Parkdale Parents' Primary Prevention Project (5P's) postnatally
- 5P's client did not sign the permission to release information on the 5P's intake form
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Program Clients
Parkdale Parents' Primary Prevention Project (5P's) clients
|
Retrospective chart review of program participation and socio-demographic & psychosocial characteristics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of program participation as assessed by review of client records and program attendance records
Time Frame: Registration to prenatal program until 12 months postpartum
|
Retrospective chart review of client program records and attendance
|
Registration to prenatal program until 12 months postpartum
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jane Francis, MSc, University of Toronto
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 34482-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prenatal Community Program
-
National Taipei University of Nursing and Health...RecruitingThe Effectiveness of Precision Nursing Intervention Program on Cognitive Function、Sleep Quality and Emotional State of Frail Femal Elderly in the CommunityTaiwan
-
Healthy Relationships CaliforniaRecruitingProgram ModalityUnited States
-
Hospices Civils de LyonRecruiting
-
Healthy Relationships CaliforniaRecruitingProgram ModalityUnited States
-
Burdur Mehmet Akif Ersoy UniversityCompleted
-
Oregon Health and Science UniversityUniversity of Michigan; University of Texas; HealthPartners Institute; Case Western... and other collaboratorsCompleted
-
PulseNmoreCompleted
-
The University of Texas Medical Branch, GalvestonCompletedPrenatal DisorderUnited States
-
Oslo University HospitalUniversity of OsloCompleted
-
Halic UniversityActive, not recruitingStress | Pregnancy Related | Noise Exposure | Prenatal Care Late | Prenatal StressTurkey
Clinical Trials on Chart review
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMalignant Central Nervous System Neoplasm | Malignant Skull Base NeoplasmUnited States
-
Louisiana State University Health Sciences Center...Recruiting
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterRecruitingCutaneous MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Recurrent Cervical Carcinoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Stage I Uterine... and other conditionsUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLCCompletedIncidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaHIV Infection | Malignant Neoplasm | Recurrent Malignant Neoplasm | Human Immunodeficiency Virus 1 PositiveMexico, Argentina, Brazil
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Neoplasm | Malignant Respiratory Tract Neoplasm | Malignant Thoracic NeoplasmUnited States, Cyprus